Less Ads, More Data, More Tools Register for FREE

Notification of Website Address

1 Aug 2007 13:44

Verona Pharma plc Notification of Website Address

Verona Pharma plc (AIM:VRP) confirms, for the purposes of AIM Rule 26, that its website address is www.veronapharma.com.

For further information please contact:

Professor Clive Page, Chairman 079 7150 4931

www.veronapharma.com

David Youngman , WH Ireland Limited 0161 832 2174

About Verona Pharma plc

Verona Pharma plc is an AIM-listed drug discovery company that is focused on finding new therapeutic drugs for the treatment of allergic rhinitis (hay fever) and other chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), as well as chronic inflammatory diseases. The Company is currently developing a long-acting bronchodilator/ anti-inflammatory drug (belonging to a class of drugs known as mixed phosphodiesterase (PDE) 3/4 inhibitors) that could be rapidly brought to clinical proof-of-concept for the treatment of hay fever and be subsequently developed for the treatment of asthma. Verona Pharma is also exploiting novel polysaccharides as potential anti-inflammatory drugs for the treatment of respiratory allergies, asthma and other inflammatory diseases.

For further information, visit the Verona Pharma website: www.veronapharma.com

VERONA PHARMA PLC

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS